# Study on Hydronidone Capsule BE

> **NCT04125056** · NA · COMPLETED · sponsor: **Beijing Continent Pharmaceutical Co, Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Hydronidone Capsule(Specification: 30 mg / grain）
- **DRUG:** Hydronidone Capsule(Specification: 15 mg / grain）

## Key facts

- **NCT ID:** NCT04125056
- **Lead sponsor:** Beijing Continent Pharmaceutical Co, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-16
- **Primary completion:** 2019-01-23
- **Final completion:** 2019-03-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04125056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04125056, "Study on Hydronidone Capsule BE". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04125056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*